English|中文
English|中文

TongliBio announces to present development of TL-010 as an orphan drug at World Orphan Drug Congress

Time：2019-04-11

4/11/2019. TongliBio annonces to present development of TL-010 as an orphan drug against schistosomiasis at World Orphan Drug Congress USA, Washington DC.


Previous： TongliBio announces to complete a clinical phase I trial with TL-010 in South Africa
Next： TongliBio announcs to receive a clearance letter from the US FDA for its IND application of TL-010
Follow us:

Email：tl.office@tonglibio.com
Telephone：86-0512-58113269
Company Address：Rm 401, Bldg D, No.1 North Guotai Rd, Zhangjiagang, Suzhou, Jiangsu Province, PRC
苏ICP备13010604号

Verification code *
Submit
COPYRIGHT (©)  Tongli Biomedical Co. (TLB) Reserved 
Technical support: Three to Five Interconnection
TOP